Stay updated on TQB2450 Combo vs K Drug in NSCLC Clinical Trial

Sign up to get notified when there's something new on the TQB2450 Combo vs K Drug in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TQB2450 Combo vs K Drug in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T07:43:57.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T22:13:34.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has updated the intervention type to 'Verified 2021-07 by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Last known status was: Recruiting' and revised to version 2.14.0, while the previous intervention type and version 2.13.3 have been removed.
    Difference
    3%
    Check dated 2025-01-12T17:41:42.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:39:58.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T15:56:37.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The website has removed the detailed options for downloading study data, including file formats and specific data fields.
    Difference
    13%
    Check dated 2024-11-23T04:35:11.000Z thumbnail image

Stay in the know with updates to TQB2450 Combo vs K Drug in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TQB2450 Combo vs K Drug in NSCLC Clinical Trial page.